The New York Stem Cell Foundation Names Dr. Derrick Rossi as Interim CEO
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO...
Learn more about NYSCF’s latest announcements, statements and research breakthroughs.
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO...
First induced pluripotent stem cell model of PTSD offers insights into underlying genetics and opportunities for new therapies (Sign up for our upcoming webinar on November...
The New York Stem Cell Foundation (NYSCF) today announced the 2022 class of NYSCF – Robertson Investigators, welcoming six outstanding stem cell researchers and neuroscientists into...
The New York Stem Cell Foundation’s (NYSCF) 16th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
NEW YORK, NY (September 9, 2022) – The New York Stem Cell Foundation (NYSCF) today announced the death of its Chief Executive Officer and Co-Founder, Susan...
New York Stem Cell Foundation (NYSCF) Research Institute collaborates with Google Research to identify new cellular characteristics of disease in skin cells from Parkinson’s patients NEW...
New York, NY (October 19, 2021) – The New York Stem Cell Foundation (NYSCF) today announced the 2021 class of NYSCF – Robertson Investigators, welcoming six...
The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer New York, New York (January 9, 2020) – The...
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
New York, NY (October 22, 2019) – The New York Stem Cell Foundation (NYSCF) today announced the 2019 class of NYSCF – Robertson Investigators, welcoming six...
The New York Stem Cell Foundation’s (NYSCF) 14th Annual Conference convenes global leaders in stem cell research to present their latest progress towards new treatments and...
Four-year Study of over 500 Research Institutions Identifies Widespread Gender Imbalance New York, NY (September 5, 2019) – Teams from the New York Stem Cell Foundation...
Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds New York, NY (January 14, 2019) – A team of scientists from...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
MEDIA ADVISORY The New York Stem Cell Foundation Conference When: Tuesday and Wednesday, October 23rd– 24th, 2018 8:30AM – 5:30PM Where: The Rockefeller University, Caspary Auditorium...
Scientific teams will develop advanced stem cell models to improve understanding and treatment of Parkinson’s, Alzheimer’s, and similar diseases New York, NY (September 12, 2018) –...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique,...
Two top scientific and business professionals recently joined NYSCF, bolstering its leadership team: Melissa J. Nirenberg, MD, PhD, FAAN has joined NYSCF as its inaugural Chief...